Results of Arthroscopic Transosseous Rotator Cuff Repair Using the ArthroCuff System: A Prospective Study

Abstract

Introduction:Rotator cuff tears are one of the common cause of shoulder pain and disability. Transosseus cuff repair is still considered as the gold standard against which other techniques are compared. We studied the functional outcome of 50 patients with rotator cuff tear treated by our novel reusable arthroscopic transosseous repair system (ArthroCuff ). Materials and methods: We performed a prospective study involving 50 patients with full thickness rotator cuff tears during the period from January 2017 to December 2107. Repair was done with the ArthroCuff system. The patients were followed up periodically at 6 months and 1 year; 2 years functional outcome was assessed for pain, Oxford Shoulder score and active range of motion. Results: At the end of 1 year and 2 years, all our patients had significant improvement in their Oxford Score, range of motion and pain relief. Two patients were trailing behind the mean at 6 months but they improved at 12 months. The results are comparable with other available transosseous systems and arthroscopic double row repair techniques. Conclusion: Arthroscopic transosseous repair though a reliable and cost-effective alternate to suture anchors, is not widely available in India. So, in association with the National Hub for Healthcare Device Development, we developed ArthroCuff. For cost-conscious countries a reusable system to provide a robust rotator cuff repair is the need of the hour and we believe surgeons and patients can benefit from the multiple advantages that exist with this system.

Surgical Technique of Arthroscopic Transosseous Implant-Less Rotator Cuff Repair Using “Arthrocuff” System

“…One reason could be the design of our jig system and the comparatively lower mean age group undergoing cuff repair in our institute. 15 Multiple advantages exist with this system: better footprint coverage, a better milieu for repaired tissue healing, and cost-effectiveness ( Table 2 ).…”